Free Trial

Zynex (ZYXI) Competitors

Zynex logo
$1.47 -0.08 (-5.16%)
Closing price 08/7/2025 04:00 PM Eastern
Extended Trading
$1.49 +0.02 (+1.36%)
As of 06:19 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZYXI vs. LNSR, RCEL, LAKE, INFU, BSGM, AVR, LUCD, ICAD, ZJYL, and FONR

Should you be buying Zynex stock or one of its competitors? The main competitors of Zynex include LENSAR (LNSR), Avita Medical (RCEL), Lakeland Industries (LAKE), InfuSystem (INFU), Biosig Technologies (BSGM), Anteris Technologies Global (AVR), Lucid Diagnostics (LUCD), icad (ICAD), Jin Medical International (ZJYL), and Fonar (FONR). These companies are all part of the "medical equipment" industry.

Zynex vs. Its Competitors

Zynex (NASDAQ:ZYXI) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.

Zynex has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500. Comparatively, LENSAR has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500.

29.7% of Zynex shares are held by institutional investors. Comparatively, 40.2% of LENSAR shares are held by institutional investors. 49.3% of Zynex shares are held by company insiders. Comparatively, 38.5% of LENSAR shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Zynex has a net margin of -19.79% compared to LENSAR's net margin of -99.17%. Zynex's return on equity of -78.54% beat LENSAR's return on equity.

Company Net Margins Return on Equity Return on Assets
Zynex-19.79% -78.54% -16.70%
LENSAR -99.17%-737.30%-81.69%

Zynex currently has a consensus price target of $4.90, suggesting a potential upside of 233.33%. LENSAR has a consensus price target of $15.00, suggesting a potential upside of 16.82%. Given Zynex's stronger consensus rating and higher probable upside, equities research analysts plainly believe Zynex is more favorable than LENSAR.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zynex
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
LENSAR
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Zynex had 7 more articles in the media than LENSAR. MarketBeat recorded 10 mentions for Zynex and 3 mentions for LENSAR. Zynex's average media sentiment score of -0.06 beat LENSAR's score of -1.00 indicating that Zynex is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Zynex
0 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
LENSAR
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative

Zynex has higher revenue and earnings than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zynex$192.35M0.23$2.99M-$0.94-1.56
LENSAR$53.49M2.83-$31.40M-$4.85-2.65

Summary

Zynex beats LENSAR on 14 of the 16 factors compared between the two stocks.

Get Zynex News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZYXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZYXI vs. The Competition

MetricZynexMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$46.96M$10.34B$5.48B$9.57B
Dividend YieldN/A2.03%3.99%4.17%
P/E Ratio-1.5619.2529.8925.14
Price / Sales0.2323.11421.4486.79
Price / Cash6.3521.8135.9458.58
Price / Book36.752.848.125.59
Net Income$2.99M$211.77M$3.26B$265.48M
7 Day Performance16.67%1.54%0.69%1.22%
1 Month Performance-39.51%2.31%2.48%0.39%
1 Year Performance-81.25%-11.48%27.93%23.47%

Zynex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZYXI
Zynex
2.7641 of 5 stars
$1.47
-5.2%
$4.90
+233.3%
-81.7%$46.96M$192.35M-1.56770Gap Up
LNSR
LENSAR
0.65 of 5 stars
$12.94
+2.6%
$15.00
+15.9%
+189.8%$148.70M$53.49M-2.67110News Coverage
Earnings Report
Upcoming Earnings
RCEL
Avita Medical
1.4012 of 5 stars
$5.35
+3.7%
$16.50
+208.4%
-32.8%$136.40M$64.25M-2.44130News Coverage
Earnings Report
LAKE
Lakeland Industries
4.6949 of 5 stars
$13.76
+3.1%
$26.00
+89.0%
-34.9%$127.02M$167.21M-4.572,100Upcoming Earnings
INFU
InfuSystem
2.8751 of 5 stars
$5.85
+2.6%
$12.50
+113.7%
N/A$122.94M$137.58M97.52410Analyst Revision
BSGM
Biosig Technologies
2.2009 of 5 stars
$4.43
+3.3%
$10.00
+125.7%
+868.7%$117.09M$40K0.0050Upcoming Earnings
AVR
Anteris Technologies Global
N/A$3.43
+11.7%
$16.50
+381.0%
N/A$110.71M$2.70M0.00138Upcoming Earnings
Gap Down
LUCD
Lucid Diagnostics
2.7803 of 5 stars
$1.02
+2.0%
$3.55
+248.0%
+25.9%$108.19M$4.35M-0.7670Positive News
Upcoming Earnings
ICAD
icad
N/A$3.87
flat
N/AN/A$106.31M$19.61M-20.37140Upcoming Earnings
ZJYL
Jin Medical International
N/A$0.64
0.0%
N/A-78.7%$100.30M$23.50M0.00245
FONR
Fonar
1.4919 of 5 stars
$15.36
-1.8%
N/A-5.4%$97.02M$102.88M12.29480

Related Companies and Tools


This page (NASDAQ:ZYXI) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners